Dexcom (NSDQ:DXCM) and Companion Medical have announced a collaboration to enable a direct exchange of continuous glucose monitoring (CGM) data from Dexcom with insulin data from InPen into both companies’ software applications. Companion made a partnership deal with Glooko this week to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data […]
glooko
Glooko, T1D Exchange ink diabetes data partnership deal
Glooko said this week that it inked an agreement with nonprofit research organization T1D Exchange to use Glooko’s diabetes management solution to incorporate anonymized diabetes data into the TID Exchange Quality Improvement Collaborative (QIC). Mountain View, Calif.-based Glooko said that the QIC is a data platform and learning collaborative made up of 11 U.S. diabetes […]
Companion Medical, Glooko ink InPen insulin pen data integration deal
Companion Medical said today that it inked a partnership deal with Glooko to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data management system and mobile application. The integration will be performed through Apple‘s (NSDQ:AAPL) Apple Health application, San Diego-based Companion Medical said, and will allow users to automatically integrate insulin data […]
Senseonics inks CGM data deal with Glooko
Senseonics (NYSE:SENS) said today that data from its Eversense continuous glucose monitoring system can be integrated into Glooko‘s diabetes data management tech. Thanks to the new partnership, Eversense users will be able to view historical glucose trends in Glooko’s mobile and web apps as well as real-time data from the Eversense mobile app, according to Senseonics. […]
Glooko, Novo Nordisk team up for connected insulin pens
Glooko announced this month that it’s teaming up to connect Novo Nordisk‘s (NYSE:NVO) insulin pens with the company’s diasend diabetes management solution. Novo Nordisk plans to launch its connected insulin pens, the NovoPen 6 and NovoPen Echo Plus, in early 2019. Any provider using diasend and any person using the diasend mobile app will be able […]
Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule
Much of Dr. Todd Hobbs’ life has centered around diabetes – he was diagnosed with Type I diabetes roughly 30 years ago and now he is the father of a child with diabetes. At his Kentucky-based primary care practice, he took on diabetic patients and helped manage their care. And when he made the jump […]
Insulet extends deal with Glooko in Europe
Insulet (NSDQ:PODD) said today that it inked a deal with Glooko to connect data from Insulet’s Omnipod insulin delivery devices in Europe with the Glooko+diasend diabetes data management system. Glooko touted that its data management tech is used at roughly 7,000 provider sites across 23 countries. The Glooko+diasend system allows users to sync and review data […]
Senseonics inks diabetes management deal with Glooko
Senseonics (NYSE:SENS) said today that it inked a global deal to integrate its Eversense continuous glucose monitoring system with Glooko‘s diabetes data management tech. Users will be able to sync data from their Eversense CGM directly into Glooko’s platform and view historical glucose trends, as well as receive real-time readings from their Eversense mobile app, according […]
DreaMed Diabetes wins FDA authorization to market insulin therapy management platform
DreaMed Diabetes said today that U.S. FDA has granted a de novo request for DreaMed Advisor Pro, its AI-based diabetes treatment decision support software. The news comes about four months after the Petah Tikva, Israel–based company won CE Mark clearance for the decision-support platform, which is meant to help healthcare professionals manage insulin therapy for people with Type […]
Glooko launches next-gen diabetes web analytics platform
Glooko said today it launched a new version of its web application, including updates to its navigation and diabetes analytics, charts and graphing capabilities. The Mountain View, Calif.-based company said the update was the result of over a year of research and development exploring “the most insightful analytics features” within its platforms. The application now […]
